Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Claturafenib is a pan-mutant B-RAF inhibitor.1 It inhibits heterodimer formation between C-RAF and B-RAF in melanoma cells expressing the B-RAFV600E activating mutation or the p61-B-RAFV600E splice variant but not wild-type B-RAF. Claturafenib reduces phosphorylated ERK levels in cell lines harboring various B-RAF mutations (IC50s = 0.7-179 nM) and decreases tumor volume in multiple mouse xenograft models of mutant B-RAF-expressing cancers.
WARNING This product is not for human or veterinary use.
1. A next-